The Management of Staphylococcal Toxic Shock Syndrome. A Case Report

1. Silversides JA, Lappin E, Ferguson AJ. Staphylococcal Toxic Shock Syndrome: Mechanisms and Management. Curr Infect Dis Rep. 2010;12:392-400.10.1007/s11908-010-0119-ySearch in Google Scholar

2. Amagai M, Yamaguchi T, Hanakawa Y, Nishifuji K, Sugai M, Stanley JR. Staphylococcal exfoliative toxin B specifically cleaves desmoglein. J Invest Dermatol. 2002;118:845-50.10.1046/j.1523-1747.2002.01751.xSearch in Google Scholar

3. Hanakawa Y, Stanley JR. Mechanisms of blister formation by staphylococcal toxins. J Biochem. 2004;136:747-50.10.1093/jb/mvh182Search in Google Scholar

4. Ladhani S. Understanding the mechanism of action of the exfoliative toxins of Staphylococcus aureus. FEMS Immunol Med Microbiol. 2003;39:181-9.10.1016/S0928-8244(03)00225-6Search in Google Scholar

5. Uchiyama T, Yan X-J, Imanishi K, Yagi J. Bacterial superantigens-mechanism of T cell activation by the superantigens and their role in the pathogenesis of infectious diseases. Microbiol Immunol. 1994;38:245–56.10.1111/j.1348-0421.1994.tb01772.x7935042Search in Google Scholar

6. Uchiyama T, Imanishi K, Miyoshi-Akiyama T, Kato H. Staphylococcal superantigens and diseases caused by them. In: Alouf JE, Popoff MR: The Comprehensive Sourcebook of Bacterial Protein Toxins, 3rd Edition. New York: Elsevier.2006;830–43.10.1016/B978-012088445-2/50055-XSearch in Google Scholar

7. Adalat S, Dawson T, Hackett SJ, Clark JE. In association with the British Paediatric Surveillance Unit. Toxic shock syndrome surveillance in UK children. Arch Dis Child. 2014;99:1078-82.10.1136/archdischild-2013-30474124790135Search in Google Scholar

8. Decleire PY, Blondiaux G, Delaere B, Glupczynski Y. Staphyloccocal scalded skin syndrome in an adult. Acta Clin Belg. 2004;59:365-8.10.1179/acb.2004.05315819382Search in Google Scholar

9. Oono T, Kanzaki H, Yoshioka T, Arata J. Staphylococcal scalded skin syndrome in an adult. Identification of exfoliative toxin A and B genes by polymerase chain reaction. Dermatology. 1997;195:268-70.10.1159/0002459589407177Search in Google Scholar

10. Shirin S, Gottlieb AB, Stahl EB. Staphylococcal scalded skin syndrome in an immunocompetent adult: possible implication of low-dosage prednisone. Cutis. 1998;62:223-4.Search in Google Scholar

11. Centers for Disease Control and Prevention. Toxic shock syndrome (other than Streptococcal) (TSS): 2011 Case Definition. 2014.Search in Google Scholar

12. Chuang YY, Huang YC, Lin TY. Toxic shock syndrome in children: epidemiology, pathogenesis, and management. Paediatr Drugs. 2005;7:11-25.10.2165/00148581-200507010-0000215777108Search in Google Scholar

13. Takahashi N, Hasegawa H, Komiyama M, et al. Selective excretion of anti-inflammatory cytokine interleukin-10 in a superantigen-inducing neonatal infectious disease. Cytokine. 2009;45:39–43.10.1016/j.cyto.2008.10.01519084429Search in Google Scholar

14. Takahashi N, Imanishi K, Uchiyama T. Overall picture of an emerging neonatal infectious disease induced by a superantigenic exotoxin mainly produced by methicillin-resistant Staphylococcus aureus. Microbiol Immunol. 2013;57:737-45.10.1111/1348-0421.1209424033495Search in Google Scholar